LRRK2 and Parkinson disease: The one study of note that most precisely demonstrated that theVPS35 mutation acts upstream of LRRK2 to regulate its kinase activity and Rab hyperphosphorylation [30] used a range of techniques, different cell lines sourced from animal models and PD patients.